Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Biodesix (BDSX) Operating Expenses (2019 - 2025)

Historic Operating Expenses for Biodesix (BDSX) over the last 7 years, with Q3 2025 value amounting to $28.8 million.

  • Biodesix's Operating Expenses rose 776.68% to $28.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was $112.7 million, marking a year-over-year increase of 1241.21%. This contributed to the annual value of $105.8 million for FY2024, which is 1702.11% up from last year.
  • Per Biodesix's latest filing, its Operating Expenses stood at $28.8 million for Q3 2025, which was up 776.68% from $29.7 million recorded in Q2 2025.
  • In the past 5 years, Biodesix's Operating Expenses ranged from a high of $34.4 million in Q1 2021 and a low of $18.9 million during Q4 2021
  • Over the past 5 years, Biodesix's median Operating Expenses value was $23.5 million (recorded in 2022), while the average stood at $24.5 million.
  • Its Operating Expenses has fluctuated over the past 5 years, first surged by 15483.8% in 2021, then tumbled by 3901.42% in 2022.
  • Quarter analysis of 5 years shows Biodesix's Operating Expenses stood at $18.9 million in 2021, then grew by 24.3% to $23.5 million in 2022, then dropped by 8.34% to $21.5 million in 2023, then rose by 25.72% to $27.1 million in 2024, then grew by 6.43% to $28.8 million in 2025.
  • Its last three reported values are $28.8 million in Q3 2025, $29.7 million for Q2 2025, and $27.1 million during Q1 2025.